Sign in
Taking people in SpainPhase 4

Tests heated mitomycin-C before bladder tumor removal in early bladder cancer

Compares heated and standard mitomycin-C treatment to reduce early bladder cancer return in adults.

Key facts

Who runs it
University Hospital Of Canary Islands
Where
San Cristobal De La Laguna, SpainSee the site
Registry title
PROSPECTIVE RANDOMISED CLINICAL TRIAL TO EVALUATE THE EARLY RECURRENCE RATE IN NON-MUSCLE INVASIVE BLADDER CANCER BETWEEN THE USE OF CHEMOHYPERTHERMIA (QH) WITH MITOMYCIN-C PRIOR TO TRANSURETHRAL BLADDER RESECTION IN A MAJOR OUTPATIENT SURGERY PROGRAMME AND TREATMENT WITH MITOMYCIN-C IN NORMOTHERMIA POST-RESECTION.
Status
Recruiting
Phase
Phase 4
People taking part
152 people, planned
Started
28 Nov 2024
Planned end
31 Mar 2026
Type of study
Interventional
Record updated
28 November 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with non-muscle invasive bladder cancer. It compares heated mitomycin-C before bladder tumour removal with mitomycin-C at normal temperature after removal.

Age
18 years or older
Sex
All sexes can join.
Disease stage
Non-muscle invasive bladder cancer.

Where in Spain

  • University Hospital Of Canary IslandsSan Cristobal De La Laguna, SpainTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Plain-language title
Tests heated mitomycin-C before bladder tumor removal in early bladder cancerGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
28 November 2024